Alpha-lipoic acid attenuates renal injury in rats with obstructive nephropathy

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Wongmekiat, Orawan ^a   Leelarungrayub, Dolrawee ^b   Thamprasert, Kamthorn ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; THIOCTIC ACID; TRANSFORMING GROWTH FACTOR BETA1; UREA; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FIBROSING ALVEOLITIS; HISTOLOGY; HYDRONEPHROSIS; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NONHUMAN; OBSTRUCTIVE NEPHROPATHY; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BLOOD UREA NITROGEN; BODY WEIGHT; CREATININE; GLUTATHIONE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84887423758     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/138719     Document Type: Article

References (27)

1. Grande M. T., Pérez-Barriocanal F., Lápez-Novoa J. M., Role of inflammation in tbulo-interstitial damage associated to obstructive nephropathy. Journal of Inflammation 2010 7, article 19 2-s2.0-77951080823 10.1186/1476-9255-7-19
2. Manucha W., Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007 31 1 1 12 2-s2.0-34248997820 (Pubitemid 46797814)
3. Chan W., Krieg R. J. Jr., Ward K., Santos F. Jr., Lin K.-C., Chan J. C. M., Progression after release of obstructive nephropathy. Pediatric Nephrology 2001 16 3 238 244 2-s2.0-0035098562 10.1007/s004670000519 (Pubitemid 32229845)
4. Dendooven A., Ishola D. A. Jr., Nguyen T. Q., Van der Giezen D. M., Kok R. J., Goldschmeding R., Joles J. A., Oxidative stress in obstructive nephropathy. International Journal of Experimental Pathology 2011 92 3 202 210 2-s2.0-79955956606 10.1111/j.1365-2613.2010.00730.x
5. Zecher M., Guichard C., Velásquez M. J., Figueroa G., Rodrigo R., Implications of oxidative stress in the pathophysiology of obstructive uropathy. Urological Research 2009 37 1 19 26 2-s2.0-59449091512 10.1007/s00240-008-0163- 3
6. Gorca A., Huk-Kolega H., Piechota A., Kleniewska P., Ciejka E., Skibska B., Lipoic acid-biological activity and therapeutic potential. Pharmacological Reports 2011 63 4 849 858 2-s2.0-80053351784
7. Abdel-Zaher A. O., Abdel-Hady R. H., Mahmoud M. M., Farrag M. M. Y., The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology 2008 243 3 261 270 2-s2.0-37149038891 10.1016/j.tox.2007.10.010 (Pubitemid 50011452)
8. Bilska A., Włodek L., Lipoic acid-the drug of the future? Pharmacological Reports 2005 57 5 570 577 2-s2.0-33644664987
9. Singh U., Jialal I., Alpha-lipoic acid supplementation and diabetes. Nutrition Reviews 2008 66 11 646 657 2-s2.0-54949103935 10.1111/j.1753-4887. 2008.00118.x
10. Smith A. R., Shenvi S. V., Widlansky M., Suh J. H., Hagen T. M., Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Current Medicinal Chemistry 2004 11 9 1135 1146 2-s2.0-2342544918 (Pubitemid 38585058)
11. Amudha G., Josephine A., Sudhahar V., Varalakshmi P., Protective effect of lipoic acid on oxidative and peroxidative damage in cyclosporine A-induced renal toxicity. International Immunopharmacology 2007 7 11 1442 1449 2-s2.0-34548126481 10.1016/j.intimp.2007.06.010 (Pubitemid 47302885)
12. Kang K. P., Kim D. H., Jung Y. J., Lee A. S., Lee S., Lee S. Y., Jang K. Y., Sung M. J., Park S. K., Kim W., Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrology Dialysis Transplantation 2009 24 10 3012 3020 2-s2.0-70349485192 10.1093/ndt/gfp242
13. Şehirli Ö., Şener E., Çetinel Ş., Yüksel M., Gedik N., Şener G., α -lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clinical and Experimental Pharmacology and Physiology 2008 35 3 249 255 2-s2.0-39149091394 10.1111/j.1440-1681.2007.04810.x (Pubitemid 351257873)
14. Cremer D. R., Rabeler R., Roberts A., Lynch B., Long-term safety of α -lipoic acid (ALA) consumption: a 2-year study. Regulatory Toxicology and Pharmacology 2006 46 3 193 201 2-s2.0-33750607920 10.1016/j.yrtph.2006.06. 003 (Pubitemid 44692904)
15. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
16. Beutler E., Beutler E., Reduced glutathione. Red Blood Cell Metabolism 1975 83 New York, NY, USA Grunne and Stratton 112 114
17. Demirbilek S., Emre M. H., Aydin E. N., Edali M. N., Aksoy R. T., Akin M., Gürünlüolu K., Tas E., Ay S., Yilmaz Z., Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction. Pediatric Nephrology 2007 22 6 804 812 2-s2.0-34247340009 10.1007/s00467-006-0416-8 (Pubitemid 46629614)
18. Liu R.-M., Gaston Pravia K. A., Oxidative stress and glutathione in TGF- β -mediated fibrogenesis. Free Radical Biology and Medicine 2010 48 1 1 15 2-s2.0-74149085153 10.1016/j.freeradbiomed.2009.09.026
19. Yanagita M., Inhibitors/antagonists of TGF-beta system in kidney fibrosis. Nephrology Dialysis Transplantation 2012 27 10 3686 3691
20. Xie X.-S., Yang M., Liu H.-C., Zuo C., Li Z., Deng Y., Fan J.-M., Influence of ginsenoside Rg1, a panaxatriol saponin from Panax notoginseng, on renal fibrosis in rats with unilateral ureteral obstruction. Journal of Zhejiang University B 2008 9 11 885 894 2-s2.0-55949093223 10.1631/jzus.B0820024
21. Chevalier R. L., Forbes M. S., Thornhill B. A., Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney International 2009 75 11 1145 1152 2-s2.0-67349203391 10.1038/ki.2009.86
22. Akin M., Demirbilek S., Ay S., Gurunluoglu K., Turkmen E., Tas E., Aksoy R. T., Baykarabulut A., Edali M. N., Attenuation of ureteral obstruction-induced renal injury by polyenylphosphatidylcholine. International Journal of Urology 2007 14 4 350 356 2-s2.0-34247570089 10.1111/j.1442-2042.2006.01717.x (Pubitemid 46669049)
23. Johnson T. S., Griffin M., Thomas G. L., Skill J., Cox A., Yang B., Nicholas B., Birckbichler P. J., Muchaneta-Kubara C., El Nahas A. M., The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. Journal of Clinical Investigation 1997 99 12 2950 2960 2-s2.0-0030986772 (Pubitemid 27278672)
24. Ying Z., Kampfrath T., Sun Q., Parthasarathy S., Rajagopalan S., Evidence that α -lipoic acid inhibits NF- B activation independent of its antioxidant function. Inflammation Research 2011 60 3 219 225 2-s2.0-79951726550 10.1007/s00011-010-0256-7
25. Chertin B., Rolle U., Farkas A., Puri P., The role of nitric oxide in reflux nephropathy. Pediatric Surgery International 2002 18 7 630 634 2-s2.0-0036820920 10.1007/s00383-002-0858-4 (Pubitemid 36069920)
26. Manucha W., Oliveros L., Carrizo L., Seltzer A., Vallés P., Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney International 2004 65 6 2091 2107 2-s2.0-2442655099 10.1111/j.1523-1755.2004.00643.x (Pubitemid 38669995)
27. Yamada M., Kaibori M., Tanaka H., Habara K., Hijikawa T., Tanaka Y., Oishi M., Okumura T., Nishizawa M., Kwon A.-H., α -lipoic acid prevents the induction of iNOS gene expression through destabilization of its mrna in proinflammatory cytokine-stimulated hepatocytes. Digestive Diseases and Sciences 2012 1 9 2-s2.0-84855178573 10.1007/s10620-011-2012-4